Patent Trolls May Soon Threaten Drug Industry, Study Says

Law360, New York (February 19, 2014, 8:51 PM EST) -- Although so-called patent trolls are widely seen as a problem primarily for the technology sector, a study released Friday claims that nonpracticing entities are changing their tactics in ways that may soon put the biotechnology and pharmaceuticals at "serious risk" of lawsuits.

The study by Robin Feldman, a professor at University of California Hastings College of the Law, and Nicholson Price, a fellow at Harvard Law School, said that the conventional wisdom that the expense of developing drug patents means that they are unlikely to be...
To view the full article, register now.